companydata.dkbiomee ApS: Financial statements 2016
CVR: 29829586
biomee ApS (CVR 29829586) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -33,025,329 and a net result of DKK -38,706,747 compared with DKK -32,989,267 the year before. Equity amounted to DKK -45,841,054.
- Gross Profit
- -33,025,329 kr.
- Profit/Loss
- -38,706,747 kr.
- Equity
- -45,841,054 kr.
- Total Assets
- 3,151,432 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -33 mio. | -38.7 mio. | -45.8 mio. | - |
| 2015 | - | -32.2 mio. | -33 mio. | -7.1 mio. | - |
| 2014 | - | -18.3 mio. | -17.2 mio. | -78.7 mio. | - |
| 2013 | - | -15.5 mio. | -18.6 mio. | -61.4 mio. | - |
| 2012 | - | -11 mio. | -11.8 mio. | -42.8 mio. | - |
How creditworthy is biomee ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
Biomee ApS has published its annual report for 2015. Gross profit came to DKK -32,170,559, and the net result was DKK -32,989,267.
About biomee ApS
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity amounted to DKK 23,772,837.